|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Allemani C, Matsuda T, Di Carlo V,
Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ,
Estève J, et al: Global surveillance of trends in cancer survival
2000-14 (CONCORD-3): Analysis of individual records for 37,513,025
patients diagnosed with one of 18 cancers from 322 population-based
registries in 71 countries. Lancet. 391:1023–1075. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Di Lorenzo G, Ricci G, Severini GM, Romano
F and Biffi S: Imaging and therapy of ovarian cancer: Clinical
application of nanoparticles and future perspectives. Theranostics.
8:4279–4294. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kuroki L and Guntupalli SR: Treatment of
epithelial ovarian cancer. BMJ. 371:m37732020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gourley C and Bookman MA: Evolving
concepts in the management of newly diagnosed epithelial ovarian
cancer. J Clin Oncol. 37:2386–2397. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rojas V, Hirshfield KM, Ganesan S and
Rodriguez-Rodriguez L: Molecular characterization of epithelial
ovarian cancer: Implications for diagnosis and treatment. Int J Mol
Sci. 17:21132016. View Article : Google Scholar
|
|
7
|
Sundar S, Neal RD and Kehoe S: Diagnosis
of ovarian cancer. BMJ. 351:h44432015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qiu L, Tang Q, Li G and Chen K: Long
non-coding RNAs as biomarkers and therapeutic targets: Recent
insights into hepato-cellular carcinoma. Life Sci. 191:273–282.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Zhang M and Zhou F: Biological
functions and clinical applications of exosomal long non-coding
RNAs in cancer. J Cell Mol Med. 24:11656–11666. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pei C, Gong X and Zhang Y: LncRNA MALAT-1
promotes growth and metastasis of epithelial ovarian cancer via
sponging microrna-22. Am J Transl Res. 12:6977–6987.
2020.PubMed/NCBI
|
|
12
|
Braga EA, Fridman MV, Moscovtsev AA,
Filippova EA, Dmitriev AA and Kushlinskii NE: LncRNAs in ovarian
cancer progression, metastasis, and main pathways: ceRNA and
alternative mechanisms. Int J Mol Sci. 21:88552020. View Article : Google Scholar :
|
|
13
|
Wambecke A, Ahmad M, Lambert B, Joly F,
Poulain L, Denoyelle C and Meryet-Figuiere M: The influence of long
non-coding RNAs on the response to chemotherapy in ovarian cancer.
Gynecol Oncol. 156:726–733. 2020. View Article : Google Scholar
|
|
14
|
Zeng S, Liu S, Feng J, Gao J and Xue F:
Upregulation of lncRNA AB073614 functions as a predictor of
epithelial ovarian cancer prognosis and promotes tumor growth in
vitro and in vivo. Cancer Biomark. 24:421–428. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu W, Gao H, Li X, Zhu Y, Peng S, Yu J,
Zhan G, Wang J, Liu N and Guo X: LncRNA TPT1-AS1 promotes
tumorigenesis and metastasis in epithelial ovarian cancer by
inducing TPT1 expression. Cancer Sci. 110:1587–1598. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao J and Liu HR: Down-regulation of long
noncoding RNA DLX6-AS1 defines good prognosis and inhibits
proliferation and metastasis in human epithelial ovarian cancer
cells via Notch signaling pathway. Eur Rev Med Pharmacol Sci.
23:3243–3252. 2019.PubMed/NCBI
|
|
17
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar :
|
|
18
|
Nguyen VHL, Yue C, Du KY, Salem M, O'Brien
J and Peng C: The role of microRNAs in epithelial ovarian cancer
metastasis. Int J Mol Sci. 21:70932020. View Article : Google Scholar :
|
|
19
|
Staicu CE, Predescu DV, Rusu CM, Radu BM,
Cretoiu D, Suciu N, Crețoiu SM and Voinea SC: Role of microRNAs as
clinical cancer biomarkers for ovarian cancer: A short overview.
Cells. 9:1692020. View Article : Google Scholar :
|
|
20
|
Khan S, Ayub H, Khan T and Wahid F:
MicroRNA biogenesis, gene silencing mechanisms and role in breast,
ovarian and prostate cancer. Biochimie. 167:12–24. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Niu ZS, Wang WH, Dong XN and Tian LM: Role
of long noncoding RNA-mediated competing endogenous RNA regulatory
network in hepatocellular carcinoma. World J Gastroenterol.
26:4240–4260. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weng W, Zhang Z, Huang W, Xu X, Wu B, Ye
T, Shan Y, Shi K and Lin Z: Identification of a competing
endogenous RNA network associated with prognosis of pancreatic
adenocarcinoma. Cancer Cell Int. 20:2312020. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Raspaglio G, Petrillo M, Martinelli E, Li
Puma DD, Mariani M, De Donato M, Filippetti F, Mozzetti S, Prislei
S, Zannoni GF, et al: Sox9 and Hif-2α regulate TUBB3 gene
expression and affect ovarian cancer aggressiveness. Gene.
542:173–181. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Malki S, Bibeau F, Notarnicola C, Roques
S, Berta P, Poulat F and Boizet-Bonhoure B: Expression and
biological role of the prostaglandin D synthase/SOX9 pathway in
human ovarian cancer cells. Cancer Lett. 255:182–193. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiao S, Li Y, Pan Q, Ye M, He S, Tian Q
and Xue M: MiR-34c/SOX9 axis regulates the chemoresistance of
ovarian cancer cell to cisplatin-based chemotherapy. J Cell
Biochem. 120:2940–2953. 2019. View Article : Google Scholar
|
|
27
|
McCabe EM and Rasmussen TP: lncRNA
involvement in cancer stem cell function and epithelial-mesenchymal
transitions. Semin Cancer Biol. Dec 17–2020.Epub ahead of print.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Qian Y, Shi L and Luo Z: Long non-coding
RNAs in cancer: Implications for diagnosis, prognosis, and therapy.
Front Med ( Lausanne). 7:6123932020. View Article : Google Scholar
|
|
29
|
Chen S and Shen X: Long noncoding RNAs:
Functions and mechanisms in colon cancer. Mol Cancer. 19:1672020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nikpayam E, Tasharrofi B, Sarrafzadeh S
and Ghafouri-Fard S: The role of long non-coding RNAs in ovarian
cancer. Iran Biomed J. 21:3–15. 2017. View Article : Google Scholar :
|
|
31
|
Tong L, Ao Y, Zhang H, Wang K, Wang Y and
Ma Q: Long noncoding RNA NORAD is upregulated in epithelial ovarian
cancer and its downregulation suppressed cancer cell functions by
competing with miR-155-5p. Cancer Med. 8:4782–4791. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zheng T, Qiu J, Li C, Lin X, Tang X and
Hua K: Long noncoding RNA LINC00673 promotes the proliferation and
metastasis of epithelial ovarian cancer by associating with opioid
growth factor receptor. Onco Targets Ther. 12:6145–6156. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qiu JJ, Lin XJ, Tang XY, Zheng TT, Zhang
XY and Hua KQ: Long noncoding RNA TC0101441 induces
epithelial-mesenchymal transition in epithelial ovarian cancer
metastasis by downregulating KiSS1. Int J Cancer. 146:2588–2598.
2020. View Article : Google Scholar
|
|
34
|
Li W, Ma S, Bai X, Pan W, Ai L and Tan W:
Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting
as a competing endogenous RNA of microRNA-18a in ovarian cancer. J
Cell Physiol. 235:1141–1154. 2020. View Article : Google Scholar
|
|
35
|
Gokulnath P, de Cristofaro T, Manipur I,
Di Palma T, Soriano AA, Guarracino MR and Zannini M: Long
non-coding RNA MAGI2-AS3 is a new player with a tumor suppressive
role in high grade serous ovarian carcinoma. Cancers (Basel). 11.
pp. 20082019, View Article : Google Scholar
|
|
36
|
Lin X, Tang X, Zheng T, Qiu J and Hua K:
Long non-coding RNA AOC4P suppresses epithelial ovarian cancer
metastasis by regulating epithelial-mesenchymal transition. J
Ovarian Res. 13:452020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qu J, Li M, Zhong W and Hu C: Competing
endogenous RNA in cancer: A new pattern of gene expression
regulation. Int J Clin Exp Med. 8:17110–17116. 2015.
|
|
38
|
Yang L, Lv Q, Liu J, Qi S and Fu D:
miR-431 regulates granulosa cell function through the IRS2/PI3K/AKT
signaling pathway. J Reprod Dev. 66:231–239. 2020. View Article : Google Scholar : PubMed/NCBI
|
